Glioblastoma
Showing NaN - NaN of 71
Glioblastoma, Anaplastic Astrocytoma, Astrocytoma Trial in New York (Adaptive Radiotherapy)
Recruiting
- Glioblastoma
- +3 more
- Adaptive Radiotherapy
-
New York, New YorkColumbia University Irving Medical Center
Oct 27, 2023
Brain Cancer, Glioblastoma, Metastatic Cancer Trial in New York (Trastuzumab deruxtecan)
Recruiting
- Brain Cancer
- +4 more
- Trastuzumab deruxtecan
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Sep 22, 2023
Glioma, Glioma, Malignant, Glioblastoma Trial in New York (Laparoscopically harvested omental tissue autograft)
Recruiting
- Glioma
- +7 more
- Laparoscopically harvested omental tissue autograft
-
New York, New YorkLenox Hill Brain Tumor Center
Jul 31, 2023
Glioma, Malignant, Glioblastoma, Glioblastoma Multiforme Trial in New York (Tissue autograft of pedicled temporoparietal fascial
Recruiting
- Glioma, Malignant
- +6 more
- Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)
-
New York, New YorkLenox Hill Brain Tumor Center
Jul 13, 2023
Genetic Testing of Cerebrospinal Fluid to Diagnose and Monitor
Recruiting
- Glioblastoma
- Lumber Puncture
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All protocol activites)
Jun 28, 2023
Anaplastic Astrocytoma, Anaplastic Astrocytoma, Not Otherwise Specified, Diffuse Intrinsic Pontine Glioma Trial in United States
Recruiting
- Anaplastic Astrocytoma
- +6 more
- Biopsy
- +3 more
-
Birmingham, Alabama
- +62 more
Feb 2, 2023
Diffuse Astrocytoma, Anaplastic Astrocytoma, Astrocytoma Trial in Worldwide (dabrafenib, trametinib)
Recruiting
- Diffuse Astrocytoma
- +22 more
-
Phoenix, Arizona
- +26 more
Jan 27, 2023
Brain Tumor Trial in Baltimore, Rochester (Exablate Model 4000)
Recruiting
- Glioblastoma
- +2 more
- Focused Ultrasound (Exablate Model 4000)
-
Miami, Florida
- +5 more
Jan 18, 2023
Glioblastoma, GBM, Glioblastoma Multiforme Trial in Los Angeles, Boston, New York (Nivolumab-Placebo, Nivolumab,
Recruiting
- Glioblastoma
- +3 more
- Nivolumab-Placebo
- +4 more
-
Los Angeles, California
- +3 more
Jan 16, 2023
Glioblastoma, Recurrent Glioblastoma Trial in United States (ASP8374, cemiplimab)
Active, not recruiting
- Glioblastoma
- Recurrent Glioblastoma
-
Boston, Massachusetts
- +3 more
Jan 13, 2023
Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)
Active, not recruiting
- Anaplastic Astrocytoma
- +2 more
- Radiation Therapy
- +2 more
-
Birmingham, Alabama
- +162 more
Dec 30, 2022
Glioblastoma Trial in United States (Abemaciclib, Surgery)
Active, not recruiting
- Glioblastoma
- Abemaciclib
- Surgery
-
Los Angeles, California
- +6 more
Dec 28, 2022
Glioblastoma Trial in Commack, Harrison, New York (Focus Group, Meaning-Centered Psychotherapy for Cancer Caregivers / MCP-C,
Active, not recruiting
- Glioblastoma
- Focus Group
- +2 more
-
Commack, New York
- +2 more
Nov 9, 2022
Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial
Recruiting
- Glioblastoma
- +8 more
- Intra-arterial Cetuximab
- +2 more
-
New York, New YorkLenox Hill Brain Tumor Center
Oct 17, 2022
Glioblastoma Trial in Canada, China, United States (drug, other, radiation)
Active, not recruiting
- Glioblastoma
- Enzastaurin Hydrochloride
- +3 more
-
Birmingham, Alabama
- +62 more
Oct 11, 2022
Advanced Malignant Solid Tumor, Glioblastoma, Recurrent Cholangiocarcinoma Trial in United States (Olaparib)
Recruiting
- Advanced Malignant Solid Neoplasm
- +6 more
-
Costa Mesa, California
- +49 more
Aug 24, 2022
Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)
Active, not recruiting
- Advanced Solid Tumors
- +7 more
- Pembrolizumab
- Lenvatinib
-
Duarte, California
- +87 more
Aug 19, 2022
Glioblastoma Trial in United States (biological, radiation, drug)
Active, not recruiting
- Glioblastoma
- INO-5401
- +4 more
-
Duarte, California
- +20 more
Aug 8, 2022